158 related articles for article (PubMed ID: 28204853)
41. Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy.
Arita J; Ono Y; Takahashi M; Inoue Y; Takahashi Y; Saiura A
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S390-7. PubMed ID: 24570378
[TBL] [Abstract][Full Text] [Related]
42. Reduced respiratory motion artifacts using structural similarity in fast 2D dynamic contrast enhanced MRI of liver lesions.
Ter Voert EE; Heijmen L; Punt CJ; de Wilt JH; van Laarhoven HW; Heerschap A
NMR Biomed; 2016 Nov; 29(11):1526-1535. PubMed ID: 27598946
[TBL] [Abstract][Full Text] [Related]
43. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS
Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
[TBL] [Abstract][Full Text] [Related]
44. New MR techniques for the detection of liver metastases.
Ward J
Cancer Imaging; 2006 May; 6(1):33-42. PubMed ID: 16766267
[TBL] [Abstract][Full Text] [Related]
45. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
[TBL] [Abstract][Full Text] [Related]
46. Feasibility for detecting liver metastases in dogs using gadobenate dimeglumine-enhanced magnetic resonance imaging.
Louvet A; Duconseille AC
Vet Radiol Ultrasound; 2015; 56(3):286-95. PubMed ID: 25529873
[TBL] [Abstract][Full Text] [Related]
47. Enhancing MRI of liver metastases with a zwitterionized biodegradable dendritic contrast agent.
Zhou X; Ye M; Han Y; Tang J; Qian Y; Hu H; Shen Y
Biomater Sci; 2017 Jul; 5(8):1588-1595. PubMed ID: 28422200
[TBL] [Abstract][Full Text] [Related]
48. Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging--comparison of optimized sequences.
Ward J; Guthrie JA; Wilson D; Arnold P; Lodge JP; Toogood GJ; Wyatt JI; Robinson PJ
Radiology; 2003 Sep; 228(3):709-18. PubMed ID: 12888620
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment.
Niekel MC; Bipat S; Stoker J
Radiology; 2010 Dec; 257(3):674-84. PubMed ID: 20829538
[TBL] [Abstract][Full Text] [Related]
50. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI].
Heim P; Steiner P; Schoder V; Dieckmann C; Kuhlencordt R; Adam G
Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107
[TBL] [Abstract][Full Text] [Related]
51. Disappearing liver metastases from colorectal cancer: impact of modern imaging modalities.
Sturesson C; Nilsson J; Lindell G; Andersson RG; Keussen I
HPB (Oxford); 2015 Nov; 17(11):983-7. PubMed ID: 26252426
[TBL] [Abstract][Full Text] [Related]
52. Liver metastases: Detection and staging.
Lincke T; Zech CJ
Eur J Radiol; 2017 Dec; 97():76-82. PubMed ID: 29153371
[TBL] [Abstract][Full Text] [Related]
53. [Computed tomography and/or magnetic resonance imaging of the liver : How, why, what for?].
Pöhler GH; Ringe KI
Radiologe; 2019 Sep; 59(9):804-811. PubMed ID: 31414150
[TBL] [Abstract][Full Text] [Related]
54. 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography, computed tomography, and magnetic resonance imaging for the detection of experimental colorectal liver metastases.
de Jong GM; Hendriks T; Bleichrodt RP; Dekker HM; Mus RD; Gotthardt M; Visser EP; Oyen WJ; Boerman OC
Mol Imaging; 2012 Apr; 11(2):148-54. PubMed ID: 22469242
[TBL] [Abstract][Full Text] [Related]
55. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium].
Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A
Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542
[TBL] [Abstract][Full Text] [Related]
56. Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging.
Park MJ; Hong N; Han K; Kim MJ; Lee YJ; Park YS; Rha SE; Park S; Lee WJ; Park SH; Lee CH; Nam CM; An C; Kim HJ; Kim H; Park MS
Radiology; 2017 Aug; 284(2):423-431. PubMed ID: 28327002
[TBL] [Abstract][Full Text] [Related]
57. [Detection of liver tumors].
Rummeny EJ; Reimer P; Daldrup H; Peters PE
Radiologe; 1995 Nov; 35(11 Suppl 2):S252-8. PubMed ID: 8588031
[TBL] [Abstract][Full Text] [Related]
58. Benefit of Contrast-Enhanced Ultrasound (CEUS) in the Follow-Up Care of Patients with Colon Cancer: A Prospective Multicenter Study.
Bernatik T; Schuler A; Kunze G; Mauch M; Dietrich CF; Dirks K; Pachmann C; Börner N; Fellermann K; Menzel J; Strobel D
Ultraschall Med; 2015 Dec; 36(6):590-3. PubMed ID: 26544634
[TBL] [Abstract][Full Text] [Related]
59. MR imaging of benign focal liver lesions.
Ba-Ssalamah A; Baroud S; Bastati N; Qayyum A
Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):403-19, ix. PubMed ID: 21094447
[TBL] [Abstract][Full Text] [Related]
60. Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?
Park YS; Lee CH; Kim JW; Shin S; Park CM
World J Gastroenterol; 2016 Jan; 22(1):284-99. PubMed ID: 26755877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
